Pharmaceutical Technology
2,914 FOLLOWERS
Pharmaceutical Technology provides procurement & reference resources for the pharmaceutical & biochemistry industries. Read Pharmaceutical news and in-depth feature articles on new drug discoveries, healthcare research and development, big pharma trends, and company deals.
Pharmaceutical Technology
33m ago
The CDE of the China NMPA has accepted Astellas Pharma’s sBLA for enfortumab vedotin plus KEYTRUDA to treat urothelial cancer ..read more
Pharmaceutical Technology
33m ago
The US FDA has extended the review period for Applied Therapeutics' NDA for govorestat to treat classic galactosemia ..read more
Pharmaceutical Technology
4h ago
Intravacc and Primrose Bio have announced a strategic collaboration aimed at bolstering the conjugate vaccine development and supply ..read more
Pharmaceutical Technology
4h ago
The EC has approved Merck’s KEYTRUDA regimen for adult patients with resectable non-small cell lung cancer at increased recurrence risk ..read more
Pharmaceutical Technology
6h ago
View the Leading Pharmaceutical Compounding Companies in Contract Manufacturing for the Pharmaceutical Industry. Download Free Guide Here ..read more
Pharmaceutical Technology
6h ago
RLS-0071 is being evaluated for the treatment of radiation poisoning, which can cause damage to the gastrointestinal tract ..read more
Pharmaceutical Technology
21h ago
Pharmaceutical Technology Has Listed the Leading Lab Equipment Suppliers to Assist in Lab Equipment Procurement. Download for Free Here ..read more
Pharmaceutical Technology
21h ago
According to the CDC, over 64 cases of measles have been documented in the US in 2024, already exceeding 2023's total of 58 ..read more
Pharmaceutical Technology
21h ago
Nanoscope Therapeutics released promising top-line results for its RESTORE trial, which is studying the gene therapy MCO-010 in patients with retinitis pigmentosa (RP ..read more
Pharmaceutical Technology
21h ago
Licensing agreements for innovator drugs utilising clustered regularly interspaced short palindromic repeats (CRISPR) technologies saw oncology, immunology, and central nervous system as the top three therapy areas by total deal value with a combined $21bn over the past five years ..read more